Chronic Kidney Disease as a Comorbidity in Heart Failure

被引:44
|
作者
Szlagor, Magdalena [1 ]
Dybiec, Jill [1 ]
Mlynarska, Ewelina [1 ]
Rysz, Jacek [2 ]
Franczyk, Beata [1 ]
机构
[1] Med Univ Lodz, Dept Nephrocardiol, Ul Zeromskiego 113, PL-90549 Lodz, Poland
[2] Med Univ Lodz, Dept Nephrol Hypertens & Family Med, Ul Zeromskiego 113, PL-90549 Lodz, Poland
关键词
heart failure (HF); chronic kidney disease (CKD); GFR; ejection fraction; renin-angiotensin-aldosterone system inhibitors (RAAS-I); mineralocorticoid receptor antagonists (MRAs); sodium-glucose cotransporter 2 inhibitors (SGLT2); kidney replacement; angiotensin receptor-neprilysin inhibitor (ARNI); uremic toxins; finerenone; REDUCED EJECTION FRACTION; CARDIORENAL SYNDROME; PERITONEAL-DIALYSIS; OXIDATIVE STRESS; RENAL-FUNCTION; ALDOSTERONE; DYSFUNCTION; MECHANISMS; OUTCOMES; ANEMIA;
D O I
10.3390/ijms24032988
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heart failure (HF) is one of the greatest problems in healthcare and it often coexists with declining renal function. The pathophysiology between the heart and the kidneys is bidirectional. Common mechanisms leading to the dysfunction of these organs result in a vicious cycle of cardiorenal deterioration. It is also associated with difficulties in the treatment of aggravating HF and chronic kidney disease (CKD) and, as a consequence, recurrent hospitalizations and death. As the worsening of renal function has an undeniably negative impact on the outcomes in patients with HF, searching for new treatment strategies and identification of biomarkers is necessary. This review is focused on the pathomechanisms in chronic kidney disease in patients with HF and therapeutic strategies for co-existing CKD and HF.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Aortic Stiffness and Heart Failure in Chronic Kidney Disease
    Monika Gawor
    Valentina O. Puntmann
    Current Cardiovascular Imaging Reports, 2020, 13
  • [22] Anemia in chronic kidney disease and congestive heart failure
    Silverberg, DS
    Wexler, D
    Blum, B
    Iaina, A
    BLOOD PURIFICATION, 2003, 21 (01) : 124 - 130
  • [23] Intravenous iron in heart failure and chronic kidney disease
    Carrilho, Patricia
    NEFROLOGIA, 2021, 41 (04): : 403 - 411
  • [24] Drug treatment of heart failure in chronic kidney disease
    Marx, Nikolaus
    INTERNIST, 2020, 61 (04): : 357 - 361
  • [25] CHRONIC KIDNEY DISEASE IN ASIAN PATIENTS WITH HEART FAILURE
    Tromp, Jasper
    Teng, Katherine T. H.
    Tay, Wan Ting
    Anand, Inder
    Zhang, Shu
    Shimizu, Wataru
    Narasimhan, Calambur
    Park, S. W.
    Yu, Cheuk-Man
    Ngarmukos, Tachapong
    Omar, Razali
    Reyes, Eugene B.
    Hung, Chung-Lieh
    Ling, Lieng
    Yap, Jonathan
    MacDonald, Michael Ross
    Richards, Mark
    Lam, Carolyn
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 933 - 933
  • [26] Chronic kidney disease, heart failure and neprilysin inhibition
    Haynes, Richard
    Zhu, Doreen
    Judge, Parminder K.
    Herrington, William G.
    Kalra, Philip A.
    Baigent, Colin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (04) : 558 - 564
  • [27] Aortic Stiffness and Heart Failure in Chronic Kidney Disease
    Gawor, Monika
    Puntmann, Valentina O.
    CURRENT CARDIOVASCULAR IMAGING REPORTS, 2020, 13 (04)
  • [28] Chronic Kidney Disease and the Risk of Heart Failure in Men
    Dhingra, Ravi
    Gaziano, J. Michael
    Djousse, Luc
    CIRCULATION-HEART FAILURE, 2011, 4 (02) : 138 - 144
  • [29] Prevention of Heart Failure in Patients with Chronic Kidney Disease
    Raghban A.
    Kirsop J.
    Tang W.H.W.
    Current Cardiovascular Risk Reports, 2015, 9 (1) : 1 - 11
  • [30] Diuretic prescribing for patients with heart failure and chronic kidney disease in decompensated heart failure
    Ryan, D. K.
    Mandarano, L.
    Anderson, L.
    Jouhra, F.
    Banerjee, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 281 - 282